In the News / Politics

FDA Approves New Schizophrenia Drug with New Mechanism of Action

By Ansha Hamid PharmD Candidate c/o 2027 Schizophrenia is a severe mental illness that is described by a list of…

1 year ago

How Political Changes Are Reshaping the Pharmaceutical Industry in 2025

By: Nivaj Haque PharmD Candidate c/o 2027 The pharmaceutical industry is undergoing significant changes in the background as new government…

1 year ago

FDA Approval of Landiolol (Rapiblyk) for Supraventricular Tachycardia

By: Nivaj Haque; PharmD Candidate c/o 2027 Recent advancements in cardiology have revolutionized the management of arrhythmias, offering new hope…

2 years ago

Clearing the Air: FDA Proposes to Sniff Out Phenylephrine from OTC Shelves

By: Christine Mauceri, PharmD Candidate c/o 2025 On November 7th, 2024, the Food and Drug Administration (FDA) announced its proposal…

2 years ago

Oxbryta’s Journey: From Accelerated Approval to Market Withdrawal

By: Amita Singh, Pharm D Candidate c/o 2025 Voxelotor, marketed under the brand name Oxbryta, was approved by the US.…

2 years ago

FDA Approves First Nasal Spray for Treatment of Anaphylaxis

By: Rebecca Sabzanov, PharmD Candidate c/o 2026 On August 9th, 2024, the Food and Drug Administration (FDA) approved Neffy, the…

2 years ago

FDA Approves Treatment for Early Symptomatic Alzheimer’s Disease, KisunlaTM (donanemab-azbt)

By: Katelyn Hoosein, PharmD Candidate c/o 2025             Alzheimer’s disease (AD) is a neurodegenerative disorder with symptoms that progressively worsen…

2 years ago

New York Providing Accessibility: Pharmacies Providing Hormonal Birth Control Without a Prescription

Amanda Nakhul, Biomedical Sciences c/o 2027 Reproductive rights, specifically abortion, has been a topic of contention for decades. From being…

2 years ago

Advancements in Fertility Treatments: IVG vs. IVF

By: Ameena Qadri PharmD Candidate c/o 2027 Advancements in reproductive technology have considerably enhanced fertility treatments, with in-vitro fertilization (IVF)…

2 years ago

Cystic Fibrosis Therapy Diminishes Hyper-Inflammation In COVID-19-Related Pneumonia

Michelle Flores, Pharm D Candidate c/o 2027 According to clinical trial results from researchers at UCL, UCLH, and the Francis…

2 years ago